SubsidieMeestersAmbiJet: the world’s first and only highly effective plasma-based solution for Europe’s 16 Million periimplantitis patients urgently needing help to avoid losing their dental implant
AmbiJet is a groundbreaking plasma-based technology that effectively eliminates bacteria on dental implants, preventing reinfection and promoting better oral and overall health.
Projectdetails
Introduction
Regular dental check-ups and treatments not only ensure a beautiful smile, but good general health. A healthy oral cavity strengthens the immune system and acts as a barrier against various heart, kidney, or lung-related diseases and diabetes.
Current Challenges
There is currently no effective solution to treat the 16.3 million infected dental implants (EU, 2019).
Innovative Solution
Freiburger Medizintechnik GmbH developed the solution dentists are looking for: a disruptive technology for highly effective infection control to fight periimplantitis.
AmbiJet Technology
AmbiJet is the world's first and only plasma-based technology with the ability to kill bacteria on dental implants in-situ. It disrupts the status quo of medical technologies by:
- Preventing the reinfection of disinfected surfaces.
- Showing maximum effectiveness without side or adverse effects.
- Eliminating the need for pharmacological and chemical substances.
Benefits
AmbiJet reduces inflammation, saves dental implants, and helps patients live a healthier life.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.389.062 |
| Totale projectbegroting | € 1.984.375 |
Tijdlijn
| Startdatum | 1-10-2022 |
| Einddatum | 30-9-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- FREIBURGER MEDIZINTECHNIK GMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Innovative multifunctional and smart coatings to prevent medical device related infectionsSPARTHA Medical develops multifunctional antimicrobial coatings and eco-friendly sprays to prevent infections in surgical implants and offers customized solutions for various industries. | EIC Accelerator | € 2.389.625 | 2022 | Details |
Advanced Sterilization Capability with Low Environmental footprint for Patient Infection Optimized SafetyAURORA's ASCLEPIOS project aims to commercialize a novel non-thermal plasma sterilization technology for medical devices, enhancing patient safety and environmental protection while boosting production capacity. | EIC Accelerator | € 2.499.139 | 2023 | Details |
Innovative multifunctional and smart coatings to prevent medical device related infections
SPARTHA Medical develops multifunctional antimicrobial coatings and eco-friendly sprays to prevent infections in surgical implants and offers customized solutions for various industries.
Advanced Sterilization Capability with Low Environmental footprint for Patient Infection Optimized Safety
AURORA's ASCLEPIOS project aims to commercialize a novel non-thermal plasma sterilization technology for medical devices, enhancing patient safety and environmental protection while boosting production capacity.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Dentale inductie verhittingIPD onderzoekt de haalbaarheid van een handheld device dat inductieverhitting gebruikt om infecties aan dentale implantaten snel te behandelen zonder ingrijpende procedures. | Mkb-innovati... | € 20.000 | 2023 | Details |
A metagenomic-based precision-medicine tool for personalized diagnosis, prognosis and treatment of oral diseasesPreBiomicsPMT aims to develop an automated precision-medicine test using metagenomics and AI to assess peri-implant plaque microbiomes, enhancing diagnosis and treatment for dental implant patients. | EIC Transition | € 2.461.900 | 2023 | Details |
Implant Preservation DeviceHet project ontwikkelt een handheld inductie-apparaat om infecties bij metalen implantaten te bestrijden, wat de chirurgische behandeling vereenvoudigt en gezondheidszorgkosten verlaagt. | Mkb-innovati... | € 289.205 | 2021 | Details |
Integrated needle-free injection and sensing using opto-microfluidicsiSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes. | EIC Transition | € 2.499.999 | 2024 | Details |
Skin micro-injectorBold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments. | ERC Proof of... | € 150.000 | 2022 | Details |
Dentale inductie verhitting
IPD onderzoekt de haalbaarheid van een handheld device dat inductieverhitting gebruikt om infecties aan dentale implantaten snel te behandelen zonder ingrijpende procedures.
A metagenomic-based precision-medicine tool for personalized diagnosis, prognosis and treatment of oral diseases
PreBiomicsPMT aims to develop an automated precision-medicine test using metagenomics and AI to assess peri-implant plaque microbiomes, enhancing diagnosis and treatment for dental implant patients.
Implant Preservation Device
Het project ontwikkelt een handheld inductie-apparaat om infecties bij metalen implantaten te bestrijden, wat de chirurgische behandeling vereenvoudigt en gezondheidszorgkosten verlaagt.
Integrated needle-free injection and sensing using opto-microfluidics
iSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes.
Skin micro-injector
Bold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments.